Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death

TURAL Ü., Onder E.

PSYCHIATRY AND CLINICAL NEUROSCIENCES, vol.64, no.1, pp.79-87, 2010 (SCI-Expanded) identifier identifier identifier


Aim: The aim of the present study was to evaluate demographics, clinical features, psychiatric diagnoses and prognosis of neuroleptic malignant syndrome (NMS) reported in Turkey, and to assess their association with mortality.